RenovaCare, Inc., a development-stage company, focuses on the acquisition, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System for spraying a patient's own skin stem cells onto burns and wounds for self-healing; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone888-398-0202
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees1
Next Earnings Date11/18/2019 (Estimated)
OptionableNot Optionable
RenovaCare (OTCMKTS:RCAR) Frequently Asked Questions
What is RenovaCare's stock symbol?
RenovaCare trades on the OTCMKTS under the ticker symbol "RCAR."
How were RenovaCare's earnings last quarter?
RenovaCare Inc (OTCMKTS:RCAR) released its quarterly earnings data on Wednesday, July, 31st. The biotechnology company reported ($0.01) earnings per share for the quarter. View RenovaCare's Earnings History.
When is RenovaCare's next earnings date?
Has RenovaCare been receiving favorable news coverage?
News stories about RCAR stock have been trending positive on Friday, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. RenovaCare earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the near future. View News Stories for RenovaCare.
Who are some of RenovaCare's key competitors?
Some companies that are related to RenovaCare include SurModics (SRDX), LeMaitre Vascular (LMAT), Antares Pharma (ATRS), Intersect ENT (XENT), SI-Bone (SIBN), Orthopediatrics (KIDS), OraSure Technologies (OSUR), MiMedx Group (MDXG), Alphatec (ATEC), GenMark Diagnostics (GNMK), Utah Medical Products (UTMD), Westaim (WEDXF), Apyx Medical (APYX), Accuray (ARAY) and Vapotherm (VAPO).
What other stocks do shareholders of RenovaCare own?
Who are RenovaCare's key executives?
RenovaCare's management team includes the folowing people:
- Ms. Patsy J. Trisler, VP of Regulatory & Clinical Affairs (Age 71)
- Mr. Harmel S. Rayat, Founder, Chairman & CEO (Age 58)
- Mr. Steve Yan-Klassen, Chief Financial Officer
- Mr. Jatinder Singh Bhogal, Chief Operating Officer (Age 52)
- Mr. Andrew Danielson, Director of Operations
How do I buy shares of RenovaCare?
Shares of RCAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is RenovaCare's stock price today?
One share of RCAR stock can currently be purchased for approximately $1.45.
How big of a company is RenovaCare?
What is RenovaCare's official website?
How can I contact RenovaCare?
RenovaCare's mailing address is 9375 E. SHEA BLVD. SUITE 107-A, SCOTTSDALE AZ, 85260. The biotechnology company can be reached via phone at 888-398-0202.
MarketBeat Community Rating for RenovaCare (OTCMKTS RCAR)
MarketBeat's community ratings are surveys of what our community members think about RenovaCare and other stocks. Vote "Outperform" if you believe RCAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
